title: Response to: Letter to the editor regarding the manuscript "Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-ProBNP target on the reduction of readmission and Mortality rAtes".
authors.affiliation: Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: susanstienen@hotmail.com.
authors.forename: Susan
authors.initials: S
authors.lastname: Stienen
authors.affiliation: Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
authors.forename: Wouter E M
authors.initials: WE
authors.lastname: Kok
mesh_terms: D005260:Female; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010359:Patient Readmission / Q000639:trends*; D010446:Peptide Fragments / Q000097:blood*; D017410:Practice Guidelines as Topic / Q000592:standards*
chemical_list: D010446:Peptide Fragments; D020097:Natriuretic Peptide, Brain